Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE GERMANY EDITION 2026

Germany’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Germany. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Germany
DE
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Germany’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Germany, snapshot 6 August 2026
Company
BioNTechbiontech.com$1.84B4,530
CureVaccurevac.com$1.41B648
ITMitm-radiopharma.com$987.29M54
MorphoSysmorphosys.com$770.07M732
Better Placebetterplace.com$710.8M85
Tubulis Technologiestubulis.com$616.69M33
Evotecevotec.com$422.61M252Financial figure available in RadarView in Radar
Viewraysystemsviewraysystems.com$333.3M
Siemens Healthineerssiemens-healthineers.com13 roles66,000
implantcastimplantcast.de11 roles
ADVITOSadvitos.com10 roles88
Brainlabbrainlab.com10 roles348Financial figure available in RadarView in Radar
Flemming Dentalflemming-dental.de10 roles46
Leica Biosystemsleicabiosystems.com10 roles365
Miltenyi Biotecmiltenyibiotec.com10 roles585Financial figure available in RadarView in Radar
Kulzerkulzer.com9 roles
AAP Implantateaap.de111
Auxiliumauxiliumgruppe.de2,352
Bentley InnoMedbentley.global194Financial figure available in RadarView in Radar
Centogenecentogene.com657Financial figure available in RadarView in Radar
Examionexamion.com40Financial figure available in RadarView in Radar
MAVIGmavig.comFinancial figure available in RadarView in Radar
Maquet Cardiopulmonarymaquet-cp.com1,000
Otto Bockottobock.com1,460
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only
THE KEY SIGNALS

Life Sciences industry KPIs in Germany

A few useful ratios bring the size of this ecosystem into perspective.

6 August 2026
Hiring participation9.2%

224 of 2,428 tracked companies have open roles.

Funding participation23.2%

564 of 2,428 tracked companies have a recorded round.

Top 3 funding share29.4%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$1.61M

Midpoint of 694 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 29.4% of disclosed capital, while 76.8% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Germany life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Germany life sciences
$0$929.18M$1.86B$2.79B$3.72B2016: $476.36M20162017: $430.95M20172018: $821.46M20182019: $835.23M20192020: $3.26B20202021: $861.15M20212022: $724M20222023: $518.04M20232024: $934.54M20242025: $972.32M2025
View the numbers
Annual life sciences funding and company formation in Germany
YearFunding (USD)FoundedRaising
2016$476.36M9466
2017$430.95M9249
2018$821.46M8355
2019$835.23M9479
2020$3.26B9075
2021$861.15M6958
2022$724M5261
2023$518.04M3836
2024$934.54M1938
2025$972.32M427
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • BioNTech12.8%
  • CureVac9.8%
  • ITM6.8%
  • Other companies70.6%

Funding by stage

916 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel173 18.9%
Series A–B181 19.8%
Series C+ / PE61 6.7%
Grants, debt & other501 54.7%

Recent recorded rounds

Latest recorded rounds · USD
8 rounds

Swipe or scroll horizontally to browse.

Seed05/2026
Sedivention $3.41M

Backed by Bmp Ventures and IBG Beteiligungsgesellschaft Sachsen-Anhalt and others.

Series A04/2026
mbiomics $14.08M

Backed by MIG Fonds and Bayern Kapital.

Seed04/2026
Tacalyx $12.88M

Backed by Boehringer Ingelheim Venture Fund and Kurma Partners and others.

Seed04/2026
Evanium $2.58M

Backed by FoodLabs and Feast Ventures.

Seed04/2026
brainjo $2.35M

Backed by HTGF and Andreas W and others.

Series A03/2026
Kupando $11.51M

Backed by Remiges Ventures and LifeCare Partners and others.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

The measured Germany identity-to-filing probe did not produce a qualifying designated legal or national-ID join: designated German registry identities do not carry the LEI or ISIN used by bundesanzeiger facts; legal-name matching is prohibited.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Germany companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Busiest websites

21 of the 2,429 companies on this page carry a measured traffic record (0.9%); these are the largest of those, by monthly visits. The median among them is 248,544 visits.

Visits and authority are third-party web estimates, not company-reported figures.

Most-installed apps

83 of these companies (3.4%) publish at least one Android app — 157 apps in all, carrying 8.2M installs between them.

AppInstallsRatingStore category
ResearchGateResearchGate2M4.6Education
CuriaCuria1.5M4.5Medical
beurer HealthManagerBeurer UK1.4M2.9Health & Fitness
beurer HealthManager ProBeurer UK716.3K3.1Health & Fitness
Preventicus HeartbeatsPreventicus548.8KMedical
Ovy – Contraception PregnancyOvy351.1K3.1Medical
INSIGHT LUNGAnimares190K4.1Medical
LaVitaLaVita182.6KHealth & Fitness
Beurer HealthCoachBeurer UK152.7K3.1Health & Fitness
HANSATON stream remotehansaton akustik gmbh122.5K3.5Medical

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q2–2025Q4).

SegmentAppsInstallsLeading appRelease trend
Life Sciences Tech343.9MResearchGate 2M
Diabetes172.6Mbeurer HealthManager 1.4M
Social Platforms22MGP-HELPER 2.5K
Disease Self Management261MPreventicus Heartbeats 548.8K
Healthcare It30637.5Kteamplay Fleet 36K
Cardiac And Vascular Disorders16610.6KHypeRate 22.6K
Wearable Technology24494.3KOvy – Contraception Pregnancy 351.1K
Women Health8416.3Ktrackle 35.7K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2023Q1: 82023Q1: 02023Q12023Q2: 52023Q2: 22023Q22023Q3: 12023Q3: 12023Q32023Q4: 12023Q4: 42023Q42024Q1: 42024Q1: 42024Q12024Q2: 32024Q2: 72024Q22024Q3: 52024Q3: 62024Q32024Q4: 32024Q4: 82024Q42025Q1: 22025Q1: 62025Q12025Q2: 22025Q2: 32025Q22025Q3: 22025Q3: 282025Q32025Q4: 52025Q4: 192025Q4

Darker bars are new releases, lighter bars apps updated. 113 of 157 apps carry a release date. The series ends at 2025Q4, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Germany life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech1,510
Medical devices570
Healthtech388
Enterprise software369
Deep tech316
Consumer digital273
Biopharmaceuticals242
Saas113
In vitro diagnostics110
Healthtech saas83
Nutritional formula66
Chronic disease management62

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

1510companies
9.9%have hiring activity

149 companies hiring · $12.34B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce1,267
E-commerce - product1,090
Subscription627
Fee-for-service405
Commission on transaction79
Advertising59
E-commerce - service36
Licensing3
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Funding roundsmbiomics.com ↗

The round includes existing investors like MIG Fonds and Bayern Kapital.

Funding roundsaignostics.com ↗

Germany-based Aignostics is applying artificial intelligence to drug development, aiming to improve both efficiency and patient outcomes.

Mergers & acquisitionsaicuris.com ↗

Business Deal Asahi Kasei Completes Acquisition of German-based Biopharmaceutical Firm Aicuris

Funding roundsbrainjo.de ↗

brainjo raised €2M seed round for VR ADHD Therapy.

Funding roundsxo-life.com ↗

Munich-based digital health startup XO Life has closed a new €4 million funding round.

Mergers & acquisitionsbiontech.com ↗

co-founded AexeRNA Therapeutics — which was itself acquired by BioNTech.

Funding roundsevanium.de ↗

Evanium - raised a funding of $2.58M in Seed round held on Apr 14, 2026.

Mergers & acquisitionstubulis.com ↗

Evotec expects to receive initial proceeds of around 100 million dollars from the sale of its stake.

Funding roundsinsight-health.de ↗

Insight Health secured $11 million in a Series A round led by Standard Capital, with participation from Pear VC, Kindred Ventures, Eudemian, ElevenLabs, and 43.

Funding roundskupando.com ↗

On Wednesday, the Schönefeld-based biopharmaceutical company announced an additional €10 million in Series A financing, taking its total Series A to €23 million.

Full recorded event mix

Top 10 categories among 958 recorded events in the 24-month window.

Earnings
184
Funding rounds
171
Leadership moves
152
Mergers & acquisitions
135
Company announcements
77
Contracts
52
IPO activity
46
Board Updates
37
Capital infusions
28
Asset acquisitions
25
7 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

49 tracked people moves

Evotec ↗
Dr. Wolfgang Hofmann

Appointment Independent Supervisory Board Member

Evotec ↗
Dieter Weinand

Appointment Chairman of the Supervisory Board

Evotec ↗
Claire Hinshelwood

Appointment Chief Financial Officer

Sartorius ↗
Florian Funck

Termination Previously Chief Financial Officer

Peter Willinger

Appointment Chief Financial Officer

Walter Miller

Resignation Previously Chief Financial Officer

BioNTech ↗
Özlem Türeci

Resignation

BioNTech ↗
Ugur Sahin

Resignation

Product launches

Products, platforms and features in the recorded window

CorTec ↗
VpCI-126 bags

Packaging film/ bags

Regulatory events

17 recorded events

Sartorius ↗

Filed declarationAMF

CureVac ↗

Final audit report deliveredEuropean Commission

CureVac ↗

CTA clearance grantedEuropean Medicines Agency

CureVac ↗

Draft audit report deliveredEuropean Commission

Litigation

5 tracked suits

Company
bayer v pfizer, biontech, moderna, johnson & johnson

patent infringementPatent ·

Company
orchid pharma v allecra therapeutics, allecra therapeutics

Asset acquisition in insolvency proceedingCivil · Verdict

Earnings pulse

Reported company results in the recorded window.

24companies
190period observations
5.0%median reported growth

Median across 103 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
bristol myers squibbBioNTech ↗Announced2026-06-02$11.1B
asahi kaseiAiCuris ↗Completed2026-04-21Not stated in snapshot
BioNTechAexeRNA Therapeutics2026-04-14Not stated in snapshot
gilead sciencesTubulis Technologies ↗Announced2026-04-12$3.1B
voyagerVERAXA ↗Announced2026-03-11Not stated in snapshot
Ashai KaseiAiCuris ↗Announced2026-02-26Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

985 postings in the preceding 12 months. The full 2,319-posting snapshot covers 109 employers.

Expand panel +

Most advertised job titles

Senior Software Engineer Ui/Ux (D/W/M)13
Data Engineer / Bi Developer (M/W/D)11
Digital Content Manager (M, W, D) B2B11
Sap Consultant Wm/Ewm Inhouse (M/W/D) Consulting, Ingenieur10
Manager Hr Servicecenter Germany D/F/M9
Labor Praktikanten (M/W/D)9
0 internship postings

19 tracked postings mention remote work.

The seniority mix

756 postings specify a level.

unspecified
1,563
manager
369
senior
189
lead
125
intern
43
entry
30

Skills employers mention

Top skills across 2,319 tracked postings in the available jobs snapshot.

Python
1
Database
1
Api Development
1
Ui Integration
1
Workflow Automation
1
THE PEOPLE BUILDING THE FIELD

Founders and leaders

1,632 founders and chief executives across 1,188 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

79 profiles with education records.

Technical University of Munich
13
University of Cambridge
9
RWTH Aachen University
6
Harvard Business School
5
Imperial College London
5
Stanford University
4
Technische Universität Berlin
4
INSEAD
4

Prior employers

10 profiles with prior-work records.

Boston Consulting Group
5
McKinsey
3
Intel
1
Google
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

22,794 articles in the measured 12-month window.

Expand panel +
22,794articles in the measured year
7,199articles in 2026Q1
86.5%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Germany · articles per complete quarter

04,8109,62014,43019,2412021Q2: 6,1352021Q22021Q3: 5,7692021Q4: 4,5172022Q1: 5,5482022Q2: 4,4602022Q22022Q3: 4,4582022Q4: 5,1892023Q1: 5,2692023Q2: 6,3042023Q22023Q3: 6,1712023Q4: 5,0192024Q1: 5,6192024Q2: 5,8582024Q22024Q3: 5,8382024Q4: 6,3152025Q1: 16,7312025Q2: 5,2682025Q22025Q3: 4,8112025Q4: 5,4392026Q1: 7,1992026Q1
View quarterly article counts
QuarterArticles
2021Q26,135
2021Q35,769
2021Q44,517
2022Q15,548
2022Q24,460
2022Q34,458
2022Q45,189
2023Q15,269
2023Q26,304
2023Q36,171
2023Q45,019
2024Q15,619
2024Q25,858
2024Q35,838
2024Q46,315
2025Q116,731
2025Q25,268
2025Q34,811
2025Q45,439
2026Q17,199

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
15,011 positive · 335 neutral · 5,233 negative
2022
16,724 positive · 439 neutral · 2,480 negative
2023
19,940 positive · 674 neutral · 2,133 negative
2024
20,245 positive · 753 neutral · 2,608 negative
2025
27,885 positive · 883 neutral · 3,460 negative

Leading coverage topics

Life Sciences coverage across Germany · ranked by full-period article count.

Covid 19 Vaccine Development And Efficacy Trials3,993 articles in the full recorded period
131 recent · 80 prior
Drug Pricing And Reimbursement Strategies3,563 articles in the full recorded period
944 recent · 800 prior
Oncology And Targeted Therapy Advancements3,124 articles in the full recorded period
741 recent · 830 prior
Rare Disease Therapies And Orphan Drugs2,566 articles in the full recorded period
562 recent · 817 prior
Covid 19 Vaccination Campaigns And Rollout Strategies2,402 articles in the full recorded period
76 recent · 34 prior
Gene Therapy And Crispr Technologies2,377 articles in the full recorded period
503 recent · 730 prior
Pharmaceutical Marketing And Sales Strategies2,257 articles in the full recorded period
682 recent · 505 prior
Generic Drug Development And Market Trends2,117 articles in the full recorded period
533 recent · 494 prior
Vaccine Research And Production Methods2,039 articles in the full recorded period
175 recent · 224 prior
Biotechnology Innovations In Medicine1,636 articles in the full recorded period
467 recent · 418 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Germany

KeywordRecentPriorChange
vaccine candidates10853104%
vaccine trials1065786%
vaccination campaigns8533158%
vaccine immunogenicity834489%
smart packaging7221243%
mass vaccination sites6814386%
temperature-sensitive packaging6415327%
anti-counterfeiting packaging5816262%
continuous manufacturing4113215%
stem cell banking119191-38%
diagnostic biotechnology79189-58%
biosimilar approval110182-40%
cell-based therapies76160-52%
gene therapy rare diseases98159-38%

Event and signal lenses

Life Sciences coverage across Germany

All complete annual cohorts shown
Rising

Regulatory Risk

31,559 classified articles

vaccine candidates, vaccine trials, stem cell banking

42.8% critical · 42.2% positive
Rising

Funding Momentum

12,129 classified articles

therapeutic development funding, biotech incubator, vaccine innovation funding

47.7% critical · 51.4% positive
Rising

Growth

31,788 classified articles

biosimilar market entry, generic drug approval, drug distribution

31.7% critical · 46.3% positive

Life Sciences coverage across Germany. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.4
202359.2
202462.0
202566.9
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Issues surrounding microbial hazards, nutritional quality, and health impacts of processed foods.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202269.7
202371.2
202476.2
202598.4
Gene and mRNA Technology HurdlesCommon problems researchers identify · 03

Gene and mRNA Technology Hurdles

711 papers

15.8% of this theme group

Barriers in gene expression, mRNA therapeutics, and cell‑culture platforms for biomedical research.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222508.3
20232505.5
20242206.6
20251725.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Problems linked to fertilizer use, nutrient efficiency, and germplasm improvement for stable yields.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221631.9
20231660.6
20241795.2
20252000.4
Plant Disease and Pest ManagementCommon problems researchers identify · 05

Plant Disease and Pest Management

691 papers

15.3% of this theme group

Complexities of host‑pathogen interactions, fungicide resistance, and integrated pest control strategies.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.7
202329.4
202427.9
202537.4
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Rising resistance in humans, livestock, and the environment threatening treatment effectiveness.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022882.3
2023835.4
2024912.9
2025968.7
Miscellaneous Biological and Chemical IssuesCommon problems researchers identify · 07

Miscellaneous Biological and Chemical Issues

423 papers

9.4% of this theme group

Broad, less‑focused concerns spanning molecular order, metabolism, and interdisciplinary research gaps.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.2
202321.4
202417.1
202512.4

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative StressCautions · 01

Cellular Toxicity and Oxidative Stress

379 papers

21.5% of this theme group

Need for careful interpretation of in‑vitro and in‑vivo assays measuring stress and viability.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221032.2
20231112.2
2024911.3
2025828.7
Genomic Selection in Plant BreedingCautions · 02

Genomic Selection in Plant Breeding

257 papers

14.6% of this theme group

Caution over translating genomic predictions into reliable trait improvements for crops.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221433.4
20231471.3
20241631.9
20251793.7
Feed Additives and Animal NutritionCautions · 03

Feed Additives and Animal Nutrition

245 papers

13.9% of this theme group

Potential unintended effects of bioactive feed compounds on animal health and sustainability.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202221.2
202319.9
202417.3
202517.6
Food Contaminants and Regulatory SafetyCautions · 04

Food Contaminants and Regulatory Safety

240 papers

13.6% of this theme group

Uncertainties surrounding novel food ingredients, additives, and their compliance with safety standards.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202292.1
202389.1
202494.2
2025105.4
DNA Damage and Repair MechanismsCautions · 05

DNA Damage and Repair Mechanisms

239 papers

13.5% of this theme group

Complexities in interpreting gene‑expression changes related to genomic stability and disease.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222414.1
20232426.1
20242133.7
20251642.1
Antibiotic Use and Co‑Selection PressuresCautions · 06

Antibiotic Use and Co‑Selection Pressures

206 papers

11.7% of this theme group

Risks of simultaneous resistance development to antibiotics, biocides, and heavy metals.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022882.3
2023835.4
2024912.9
2025968.7
Pesticide Resistance ManagementCautions · 07

Pesticide Resistance Management

199 papers

11.3% of this theme group

Challenges in designing dose strategies and biological controls to curb evolving pest resistance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.0
202365.3
202466.9
202576.7

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging ToolsOpportunities · 01

Advanced Antibody and Imaging Tools

1,044 papers

17.4% of this theme group

Promising platforms using fluorescent antibodies and flow cytometry for in‑vivo diagnostics.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022560.8
2023617.6
2024466.3
2025459.8
Gene Regulation for Therapeutic TargetsOpportunities · 02

Gene Regulation for Therapeutic Targets

1,032 papers

17.2% of this theme group

Opportunities in modulating apoptosis and cell growth through knockdown and up‑regulation techniques.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022362.8
2023394.7
2024255.9
2025266.9
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Emerging health‑focused ingredients and antioxidants from plant sources for sustainable diets.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202325.8
202427.4
202544.8
Epigenetic and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Innovations in DNA methylation profiling and messenger‑RNA detection for disease monitoring.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222396.5
20232385.8
20242123.6
20251641.4
Novel Antimicrobials and PostbioticsOpportunities · 05

Novel Antimicrobials and Postbiotics

809 papers

13.5% of this theme group

Exploration of plant‑derived compounds and microbial metabolites to combat resistance.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.2
2024556.9
2025654.9
Genetic Improvement of GermplasmOpportunities · 06

Genetic Improvement of Germplasm

717 papers

11.9% of this theme group

Leveraging quantitative trait loci and selection to boost crop yield and quality.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202252.7
202345.3
202439.3
202541.1
Sustainable Biomass and Biofuel StrategiesOpportunities · 07

Sustainable Biomass and Biofuel Strategies

697 papers

11.6% of this theme group

Utilizing microbial fermentation and agri‑food by‑products for eco‑friendly energy and materials.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221511.1
20231558.6
20241735.8
20251952.4

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.5%
Promising30.4%36.6%
Breakthrough14.1%26.5%
Problem-identifying8.3%9.9%
Cautionary3.5%4.2%
Comparative2.4%4.2%
Critical1.0%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Germany: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 6 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon